Clinical Trial Update: Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating efficacy and tolerance of bevacizumab in Her2-negative inflammatory breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED